Abstract

To prospectively evaluate a logistic regression-based machine learning (ML) prognostic algorithm implemented in real-time as a clinical decision support (CDS) system for symptomatic persons under investigation (PUI) for Coronavirus disease 2019 (COVID-19) in the emergency department (ED). We developed in a 12-hospital system a model using training and validation followed by a real-time assessment. The LASSO guided feature selection included demographics, comorbidities, home medications, vital signs. We constructed a logistic regression-based ML algorithm to predict "severe" COVID-19, defined as patients requiring intensive care unit (ICU) admission, invasive mechanical ventilation, or died in or out-of-hospital. Training data included 1,469 adult patients who tested positive for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) within 14 days of acute care. We performed: 1) temporal validation in 414 SARS-CoV-2 positive patients, 2) validation in a PUI set of 13,271 patients with symptomatic SARS-CoV-2 test during an acute care visit, and 3) real-time validation in 2,174 ED patients with PUI test or positive SARS-CoV-2 result. Subgroup analysis was conducted across race and gender to ensure equity in performance. The algorithm performed well on pre-implementation validations for predicting COVID-19 severity: 1) the temporal validation had an area under the receiver operating characteristic (AUROC) of 0.87 (95%-CI: 0.83, 0.91); 2) validation in the PUI population had an AUROC of 0.82 (95%-CI: 0.81, 0.83). The ED CDS system performed well in real-time with an AUROC of 0.85 (95%-CI, 0.83, 0.87). Zero patients in the lowest quintile developed "severe" COVID-19. Patients in the highest quintile developed "severe" COVID-19 in 33.2% of cases. The models performed without significant differences between genders and among race/ethnicities (all p-values > 0.05). A logistic regression model-based ML-enabled CDS can be developed, validated, and implemented with high performance across multiple hospitals while being equitable and maintaining performance in real-time validation.

Highlights

  • The dynamic of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection raised concerns regarding resource availability throughout medical systems, including intensive care unit (ICU) healthcare providers, personal protective equipment, total hospital, and ICU beds, and mechanical ventilators

  • The models performed without significant differences between genders and among race/ethnicities

  • Significant difference in all variables in demographics, use of home medications, comorbidities, and 24-hour vitals existed across training and validation cohorts, except for loop diuretic, inflammatory bowel disease, and rheumatoid arthritis

Read more

Summary

Introduction

The dynamic of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection raised concerns regarding resource availability throughout medical systems, including intensive care unit (ICU) healthcare providers, personal protective equipment, total hospital, and ICU beds, and mechanical ventilators. On March 11th, 2020, the World Health Organization declared the Coronavirus disease 2019 (COVID-19) a pandemic. The COVID-19 pandemic has caused over 249 million confirmed infections and over 5 million confirmed deaths as of November 9th, 2021 [1]. One of the initial large observational studies, published from China, revealed that approximately 15% of the confirmed cases required hospitalization, 5% needed ICU admission, and 2.3% died [2]. A multihospital United States (U.S.) based cohort study identified that the 30-day mean risk standardized event rate of hospital mortality and hospice referral among patients with COVID-19 varied from 9% to 16%, with better outcomes occurring in community’s with lower disease prevalence [3]. A large cross-sectional study found racial and ethnic disparities in rates of COVID-19 hospital and ICU admission and in-hospital mortality in the US [4]

Methods
Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.